Canada markets closed

Khiron Life Sciences Corp. (KHRN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0950+0.0050 (+5.56%)
At close: 03:59PM EDT
Full screen
Previous Close0.0900
Open0.0950
Bid0.0950 x 0
Ask0.1000 x 0
Day's Range0.0950 - 0.0950
52 Week Range0.0850 - 0.2900
Volume49,900
Avg. Volume203,522
Market Cap20.557M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateNov 21, 2022 - Nov 25, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.38
  • CNW Group

    Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Europe and Latin America, today announced that received the Best Latin American Cannabis Company award at Benzinga's 2022 Cannabis Capital Conference in Chicago.

  • CNW Group

    Khiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe including Stellar Genetics from California

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Europe and Latin America, announces its new medical product portfolio in Europe. The new products, which are already being promoted to prescribers, pharmacies, and patients, will be exclusively distributed through Khiron's wholly-owned Pharmadrug Production GmbH and will be available to pharmacies and patients in Germany and the UK in the coming w

  • CNW Group

    Khiron Life Sciences Reports Second Quarter 2022 Financial Results

    Khiron Life Sciences Corp. ("Khiron" or the "Corporation") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Latin America and Europe, announced today its financial results for the quarter ended June 30, 2022. These filings are available for review on the Corporation's SEDAR profile at www.sedar.com. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.